LARIAM 250 mg, scored tablet 8 tablets
Active ingredients: Mefloquine, MÉFLOQUINE (CHLORHYDRATE DE)
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Scored tablet8 tabletsorale
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- LARIAM 250 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC-aluminium de 8 comprimé(s)
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention du paludisme pour certains assurés sociaux de Guyane ; JOURNAL OFFICIEL ; 14/02/07
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1996
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65999556CIP73396168CIP133400933961688Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉFLOQUINE (CHLORHYDRATE DE)comprimé | 274,09 mg · un comprimé | SA |
| MÉFLOQUINEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.